Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience

Saved in:
Bibliographic Details
Main Authors: Andrea Angeletti, Gianluca Caridi, Xhuliana Kajana, Carolina Bigatti, Agnese Spennacchio, Decimo Silvio Chiarenza, Gabriele Mortari, Paolo Cravedi, Enrico E. Verrina
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024925003894
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839604013830504448
author Andrea Angeletti
Gianluca Caridi
Xhuliana Kajana
Carolina Bigatti
Agnese Spennacchio
Decimo Silvio Chiarenza
Gabriele Mortari
Paolo Cravedi
Enrico E. Verrina
author_facet Andrea Angeletti
Gianluca Caridi
Xhuliana Kajana
Carolina Bigatti
Agnese Spennacchio
Decimo Silvio Chiarenza
Gabriele Mortari
Paolo Cravedi
Enrico E. Verrina
author_sort Andrea Angeletti
collection DOAJ
format Article
id doaj-art-46aa2a25a6ee45ac835b72affa5b5b51
institution Matheson Library
issn 2468-0249
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-46aa2a25a6ee45ac835b72affa5b5b512025-08-02T04:47:28ZengElsevierKidney International Reports2468-02492025-08-0110828732874Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center ExperienceAndrea Angeletti0Gianluca Caridi1Xhuliana Kajana2Carolina Bigatti3Agnese Spennacchio4Decimo Silvio Chiarenza5Gabriele Mortari6Paolo Cravedi7Enrico E. Verrina8Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy; Correspondence: Andrea Angeletti, Nephrology, Dialysis and Transplantation; IRCCS Istituto Giannina Gaslini, Via Gaslini 5, 16147 Genova GE, Italy.Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, ItalyNephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, ItalyNephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy; Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USANephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, ItalyNephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, ItalyNephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, ItalyDepartment of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USANephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italyhttp://www.sciencedirect.com/science/article/pii/S2468024925003894
spellingShingle Andrea Angeletti
Gianluca Caridi
Xhuliana Kajana
Carolina Bigatti
Agnese Spennacchio
Decimo Silvio Chiarenza
Gabriele Mortari
Paolo Cravedi
Enrico E. Verrina
Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience
Kidney International Reports
title Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience
title_full Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience
title_fullStr Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience
title_full_unstemmed Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience
title_short Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience
title_sort obinutuzumab in rituximab resistant podocytopathies a single center experience
url http://www.sciencedirect.com/science/article/pii/S2468024925003894
work_keys_str_mv AT andreaangeletti obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience
AT gianlucacaridi obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience
AT xhulianakajana obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience
AT carolinabigatti obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience
AT agnesespennacchio obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience
AT decimosilviochiarenza obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience
AT gabrielemortari obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience
AT paolocravedi obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience
AT enricoeverrina obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience